Insecticides (India) Ltd (INSECTICID) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Insecticides India Ltd. (IEL) reported strong revenue growth of 32% in Q4 FY25, driven by premium products and new launches.
- Gross profit margin improved to 13%, a 655 bps increase YoY, attributed to better product mix, improved pricing, and new launches.
- EBITDA margin also saw improvement, increasing by 281 bps YoY.
- The company launched 12 new products in FY25, with 4 shifting to Focus Marathas, increasing the total from 12 to 16.
- Dahej plant received in-principle approval and is expected to start production in June 2025, projected to contribute roughly 100 crores this fiscal year.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.